Home
Discover
Trends
Leaders
Trending Assets
Top investors this month
Trending Assets
Top investors this month
PostsTradesAbout
Statistics
Open152.11
High154.36
Low145.75
Volume208.5k
Mkt Cap16.1B
P/E Ratio-569.13
52w High265.00
52w Low129.52
Avg Vol158.8k
Yield-/-
Beta0.79
EPS-0.27
Data delayed by 15 minutes.
Categories
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
About
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.
CEOJohn Oyler
HQChangping District, Beijing
Employees5,300
Asset statistics
Commonstock is a social network that amplifies the knowledge of the best investors, verified by actual track records for signal over noise. Community members can link their existing brokerage accounts and share their real time portfolio, performance and trades (by percent only, dollar amounts never shared). Commonstock is not a brokerage, but a social layer on top of existing brokerages helping to create more engaged and informed investors.
AboutBlogCareersBrand Kit
Terms of ServiceCopyright PolicyPrivacy PolicySecurity
Already have an account?